Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors

被引：0
|
作者：
Jonsdottir, Gudbjorg
Bjorkholm, Magnus
Turesson, Ingemar
Hultcrantz, Malin
Porwit, Anna
Jethava, Yogesh
Landgren, Ola
Kristinsson, Sigurdur Y.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4396
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Pathway Analysis of Molecular Mutations Can Modify Morphologic, Cytogenetic and Prognostic Risk Stratification Schemes in Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes/Myeloproliferative Neoplasms (MDS/MPN), and Secondary Acute Myeloid Leukemia (AML)
    Hasrouni, Edy
    Visconte, Valeria
    Tabarroki, Ali
    Rogers, Heesun J.
    Traina, Fabiola
    Jankowska, Anna
    Liu, Yang
    Hamilton, Betty K.
    Bupathi, Manoj
    Makishima, Hideki
    Jerez, Andres
    Copelan, Edward A.
    Advani, Anjali
    McDevitt, Michael A.
    Kalaycio, Matt
    Saunthararajah, Yogen
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw P.
    Tiu, Ramon V.
    BLOOD, 2012, 120 (21)
  • [42] Phase II study of Mylotarg plus Troxatyl in patients with refractory acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).
    Giles, FJ
    Garcia-Manero, G
    O'Brien, S
    Estey, E
    Kantarjian, H
    BLOOD, 2001, 98 (11) : 212B - 212B
  • [43] Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study
    David P. Steensma
    Medrdad Abedi
    Rafael Bejar
    Christopher R. Cogle
    Kathryn Foucar
    Guillermo Garcia-Manero
    Tracy I. George
    David Grinblatt
    Rami Komrokji
    Xiaomei Ma
    Jaroslaw Maciejewski
    Daniel A. Pollyea
    Michael R. Savona
    Bart Scott
    Mikkael A. Sekeres
    Michael A. Thompson
    Arlene S. Swern
    Melissa Nifenecker
    Mary M. Sugrue
    Harry Erba
    BMC Cancer, 16
  • [44] Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study
    Steensma, David P.
    Abedi, Medrdad
    Bejar, Rafael
    Cogle, Christopher R.
    Foucar, Kathryn
    Garcia-Manero, Guillermo
    George, Tracy I.
    Grinblatt, David
    Komrokji, Rami
    Ma, Xiaomei
    Maciejewski, Jaroslaw
    Pollyea, Daniel A.
    Savona, Michael R.
    Scott, Bart
    Sekeres, Mikkael A.
    Thompson, Michael A.
    Swern, Arlene S.
    Nifenecker, Melissa
    Sugrue, Mary M.
    Erba, Harry
    BMC CANCER, 2016, 16
  • [45] PHF6 Somatic Mutations and Their Functional Role in the Pathophysiology of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
    Przychodzen, Bartlomiej P.
    Gu, Xiaorong
    You, Dewen
    Hirsch, Cassandra M.
    Clemente, Michael J.
    Sekeres, Mikkael A.
    Nazha, Aziz
    Makishima, Hideki
    Maciejewski, Jaroslaw P.
    BLOOD, 2016, 128 (22)
  • [46] Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma
    Jonsdottir, Gudbjorg
    Bjorkholm, Magnus
    Turesson, Ingemar
    Hultcrantz, Malin
    Diamond, Benjamin
    Porwit, Anna
    Landgren, Ola
    Kristinsson, Sigurdur Y.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (02) : 275 - 282
  • [47] RISK ASSESSMENT IN MYELODYSPLASTIC SYNDROMES (MDS)
    Improta, S.
    Gagliardi, A.
    Lucania, A.
    Della Cioppa, P.
    Villa, M. R.
    Esposito, M.
    Quirino, A.
    Mastrullo, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 556 - 557
  • [48] Isolation of specific and biologically active peptides that bind cells from patients with acute myeloid leukemia (AML) and high risk myelodysplastic syndromes (MDS).
    Devemy, EM
    Galili, N
    Reddy, PL
    Venugopal, P
    Raza, A
    Preisler, HD
    BLOOD, 2002, 100 (11) : 374A - 374A
  • [49] Results of 5-azacitidine therapy in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)
    Freyrie, A.
    Reda, G.
    Vincenti, D.
    Ferla, V.
    Orofino, N.
    Sciume, M.
    Guidotti, F.
    Cortelezzi, A.
    LEUKEMIA RESEARCH, 2013, 37 : S157 - S158
  • [50] Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in Down syndrome: Pathologic aspects
    Mast, K.
    Taub, J. W.
    Alonzo, T.
    Mosse, C.
    Gamis, A. S.
    Mathew, P.
    Jones, H.
    Hitzler, J.
    Head, D. R.
    LEUKEMIA RESEARCH, 2013, 37 : S89 - S90
12345